NEU vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

NEU

62.8
AI Score
VS
NEU Wins

CBT

42.6
AI Score

Investment Advisor Scores

NEU

63score
Recommendation
BUY

CBT

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NEU CBT Winner
Forward P/E 22.5225 9.9404 CBT
PEG Ratio 5.6368 1.0017 CBT
Revenue Growth 7.0% 6.4% NEU
Earnings Growth 22.9% -93.7% NEU
Tradestie Score 62.8/100 42.6/100 NEU
Profit Margin 15.8% 5.2% NEU
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD NEU

Relative Price Performance (Last 90 Days)

NEU 1M: -0.4% · 3M: +14.9% CBT 1M: -7.2% · 3M: -17.2%

Current Technical Phase

NEU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $884.98

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 34

RSI (14): 34.2 · Price: $73.78

Fundamentals Snapshot

Metric NEU CBT
Market Cap — —
Forward P/E 22.5 10.6
Trailing P/E 18.9 20.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.2%
Operating Margin 0.2% 0.1%
EPS 46.47 3.57
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, NEU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.